Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 2011 Feb 17;364(7):688-9

Date

02/18/2011

Pubmed ID

21323562

DOI

10.1056/NEJMc1012774

Scopus ID

2-s2.0-79951847934 (requires institutional sign-in at Scopus site)   33 Citations

Author List

Brinkerhoff BT, Poetker DM, Choong NW

Author

David M. Poetker MD Chief, Professor in the Otolaryngology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Epistaxis
Hemoglobins
Humans
Infusions, Intravenous
Male
Middle Aged
Telangiectasia, Hereditary Hemorrhagic